Ben Markman

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• The University of Texas MD Anderson Cancer Center10.1%
• Memorial Sloan Kettering Cancer Center9.8%
• Sichuan University9%
• Harvard University8.4%
• Novartis (Switzerland)7.7%
• Chinese Academy of Medical Sciences & Peking Union Medical College7.7%
• Other47.3%

Fields

• Medicine52.9%
• Biochemistry, Genetics and Molecular Biology37%
• Immunology and Microbiology3.7%
• Neuroscience1.9%
• Pharmacology, Toxicology and Pharmaceutics1.1%
• Materials Science1%
• Other2.4%

Topics

• Cancer Immunotherapy and Biomarkers18.6%
• PI3K/AKT/mTOR signaling in cancer17.5%
• Lung Cancer Treatments and Mutations6.8%
• Cancer Mechanisms and Therapy6.7%
• Adenosine and Purinergic Signaling5.9%
• Immune Cell Function and Interaction5.8%
• Other38.6%